Tetrahedron Letters
Synthesis of (R)-propane-1,2-diol from lactides by dynamic kinetic
resolution
a
b
b
a,c,
Ivan A. Shuklov a, , Natalia V. Dubrovina , Joachim Schulze , Wolfgang Tietz , Armin Börner
⇑
⇑
a Leibniz-Institut für Katalyse an der Universität Rostock e.V., Albert-Einstein Straße 29a, 18059 Rostock, Germany
b ThyssenKrupp Industrial Solutions GmbH, Am Haupttor, Bau 3668, 06237 Leuna, Germany
c Institut für Chemie der Universität Rostock, A.-Einstein-Str. 3a, 18059 Rostock, Germany
a r t i c l e i n f o
a b s t r a c t
Article history:
The dynamic kinetic resolution (DKR) of rac-1-tert-butoxypropan-2-ol with isopropenyl acetate in the
presence of Novozyme 435 and a ruthenium catalyst produces enantiomerically pure (R)-1-tert-but-
oxy-2-acetoxy-propane (>99.5 %ee) in a good yield. The product can be easily transformed into (R)-pro-
pane-1,2-diol without loss of stereoselectivity. Together with recently published procedures, the herein
described DKR offers the possibility to use any lactide source as starting material for the production of
(R)-propane-1,2-diol. The chiral diol may serve as the chiral building block for the synthesis of important
enantiopure esters, like propylene carbonate, chiral polymers, etc.
Received 7 February 2014
Revised 23 April 2014
Accepted 25 April 2014
Available online xxxx
Keywords:
Propane-1,2-diol
Lactide
Ó 2014 Elsevier Ltd. All rights reserved.
Dynamic kinetic resolution
Ruthenium
PLLA
Lipase
Introduction
mely high prices of unnatural (R)-lactic acid and all its
derivatives such as (R,R)-dilactide or poly-D
-lactic acid (PDLA).6
Propane-1,2-diol (1,2-propylene glycol) is produced industrially
from propylene via propylene oxide (HPPO process).1 The annual
production is close to 1 Mio tons.2 The main part of this material
is employed for the manufacture of polyesters or polyurethanes.
Alternatively, it may serve for the production of propylene carbon-
ate (PC), which is a valuable and environmentally friendly solvent
for numerous applications.3 Usually the racemic diol is used how-
ever, an easy access to the enantiopure propane-1,2-diol would
offer new fields of application. Nonracemic 1,2-propandiol is
already frequently used as a chiral building block in the synthesis
of pharmaceuticals.4
Therefore we looked for an alternative procedure, which allows
to utilize rac-propane-1,2-diol and thus eventually any form of dil-
actide as the starting material, namely (S,S)-dilactide, rac-dilactide,
or even meso-dilactide. Our new approach to (R)-propane-1,2-diol
is based on the dynamic kinetic resolution (DKR)7 of the monopro-
tected diol proceeding via an Ru-catalyzed epimerization of the
alcohol combined with a highly stereodiscriminating enzymatic
acylation.
Results and discussion
Recently we discovered an ecologically benign access to pro-
pane-1,2-diol by a one pot alcoholysis-hydrogenation procedure
using di-, oligo-, and polylactides as feed (Scheme 1).5 At high tem-
peratures (150 °C) racemic propane-1,2-diol was formed. Interest-
ingly by use of enantiopure (S,S)-dilactide or poly-L-lactic acid
(PLLA) at lower temperatures (S)-propane-1,2-diol could be
obtained in the best case with 98 %ee.
For the DKR a properly 1-O-protected rac-propane-1,2-diol was
required (Scheme 1). The protective group should be inert towards
the conditions of the Ru-catalyzed DKR, cheap, and easily remov-
able after the transformation. As two promising candidates 1-ben-
zyloxypropane-2-ol (1a) and 1-tert-butoxypropan-2-ol (1b) were
selected. Both compounds could be synthesized by selective ether-
ification of propane-1,2-diol.8,9
Up to now, the kinetic resolution of rac-1-benzyloxypropan-2-
ol (1a) was unknown. Therefore the reaction has to be optimized
first. Two commercially available immobilized enzymes that are
stable also at high temperatures were chosen namely Candida ant-
arctica B (Novozyme 435) and Pseudomonas cepacia (Amano PS)
(Table 1).
Clearly, the same transformation with the opposite stereoiso-
mer is possible, but economically irrelevant because of the extre-
⇑
Corresponding authors.
0040-4039/Ó 2014 Elsevier Ltd. All rights reserved.